Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
May 13, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
May 06, 2024 02:00 ET
|
Cellectis Inc.
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
May 02, 2024 16:30 ET
|
Cellectis Inc.
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
April 24, 2024 10:00 ET
|
Autolus Therapeutics plc
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL at ASCO
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
April 23, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
April 22, 2024 16:30 ET
|
Cellectis Inc.
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs at ASGCT 2024
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
April 15, 2024 16:05 ET
|
Cargo Therapeutics, Inc.
SAN MATEO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell...
Global and China Passenger Car T-Box Industry Research 2024 Featuring 8 International Suppliers and 31 Chinese Suppliers
April 09, 2024 07:18 ET
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global and China Passenger Car T-Box Market Report, 2024" report has been added to ResearchAndMarkets.com's offering.Global and China Passenger Car...
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
April 08, 2024 16:30 ET
|
Cellectis Inc.
Cellectis announces that preliminary data exploring novel TALEN® editing process in HSPCs will be presented at ASGCT 2024
Monthly information on share capital and company voting rights
April 04, 2024 16:30 ET
|
Cellectis Inc.
PARIS, April 04, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...